colistimethate sodium has been researched along with colistin in 180 studies
| Studies (colistimethate sodium) | Trials (colistimethate sodium) | Recent Studies (post-2010) (colistimethate sodium) | Studies (colistin) | Trials (colistin) | Recent Studies (post-2010) (colistin) |
|---|---|---|---|---|---|
| 188 | 12 | 140 | 5,449 | 198 | 3,262 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (6.67) | 18.7374 |
| 1990's | 2 (1.11) | 18.2507 |
| 2000's | 20 (11.11) | 29.6817 |
| 2010's | 126 (70.00) | 24.3611 |
| 2020's | 20 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Hattori, M; Kaneko, Y; Kumai, R; Maseki, N; Sakurai, M; Sampi, K | 1 |
| Boisseau, J; Moretain, JP | 1 |
| Horton, J; Pankey, GA | 1 |
| Albers, AC; Benko, B; Davis, L; Freedel, DN; Matuscak, RR; Raneri, S; Sniffen, JM | 1 |
| Salit, IE; Skidmore, AG; Smith, JA | 1 |
| Kondo, S; Mitsuhashi, Y; Sasaki, S | 1 |
| Corbella, X; Corral, L; Fernandez-Viladrich, P; Mateu, A; Tubau, F | 1 |
| Coulthard, K; Li, J; Milne, R; Nation, RL; Turnidge, J | 1 |
| Giamarellos-Bourboulis, EJ; Giamarellou, H; Xirouchaki, E | 1 |
| Coulthard, K; Li, J; Milne, RW; Nation, RL; Turnidge, JD; Valentine, J | 1 |
| Coulthard, K; Li, J; Milne, RW; Nation, RL; Turnidge, JD | 1 |
| HOLLOWAY, WJ; SCOTT, EG | 1 |
| MANN, PH | 1 |
| ARMENIA, JV; JONES, WY | 1 |
| CARROLL, G | 1 |
| BAINES, RD; RIFKIND, D | 1 |
| DOHI, I; FUJIMORI, I; ITO, S; KATSU, M; OGAWA, J; TAKAHASHI, M; TAKEKAWA, S | 1 |
| NIXON, M; RODGER, KC; TONNING, HO | 1 |
| Conway, S; Coulthard, K; Etherington, C; Li, J; Milne, R; Nation, RL; Peckham, D; Turnidge, J | 1 |
| Coulthard, K; Li, J; Milne, RW; Nation, RL; Smeaton, TC; Turnidge, JD | 1 |
| García-Rodríguez, JA; Muñoz Bellido, JL | 1 |
| Li, J | 1 |
| Boots, R; Deans, R; Douglas, A; Li, J; Lipman, J; Nation, RL; Rayner, CR; Widdecombe, N | 1 |
| Hovde, LB; Kroeger, LA; Mitropoulos, IF; Rotschafer, JC; Schafer, J | 1 |
| Franklin, C; Li, J; Nation, RL; Owen, RJ; Spelman, D; Wong, S | 1 |
| McCoy, KS | 1 |
| David, MD; Gill, MJ | 1 |
| Boyle, DA; Frieden, J; Headley, D; Helmich, C; Hurst, S; Martin, M; Montefour, K | 1 |
| Martin, SI; Moffatt-Bruce, S; Nunley, DR; Pope-Harman, A; Ross, P; Sopirala, MM | 1 |
| Li, J; Zavascki, AP | 1 |
| Coulthard, K; Li, J; Nation, RL; Rayner, CR; Wallace, SJ | 1 |
| Antoniadou, A; Armaganidis, A; Cars, O; Friberg, LE; Giamarellou, H; Karaiskos, I; Karvanen, M; Kontopidou, F; Papadomichelakis, E; Plachouras, D; Poulakou, G; Tsangaris, I | 1 |
| Ake, J; Hartzell, JD; Howard, R; Neff, R; Olson, S; Paolino, K; Vishnepolsky, M; Weintrob, A; Wortmann, G | 1 |
| Costa, SF; Grinbaum, RS; Levin, AS; Oliveira, MS; Prado, GV | 1 |
| Celebi, S; Cetinkaya, M; Hacimustafaoglu, M; Koksal, N; Ozkan, H | 1 |
| Boyd, BJ; Li, J; Nation, RL; Prankerd, RJ; Velkov, T; Wallace, SJ | 1 |
| Bauldoff, GS; Mangino, JE; Nunley, DR; Pope-Harman, AL | 1 |
| Cacciarelli, TV; Muder, RR; Shields, RK; Singh, N; Sun, HY | 1 |
| Imberti, R | 1 |
| Angkasekwinai, N; Lorsutthitham, J; Rattanaumpawan, P; Thamlikitkul, V; Ungprasert, P | 1 |
| Anderson, D; Bulitta, JB; Forrest, A; Jarkowski, A; Lim, LM; Ly, N; Macander, L; Tsuji, BT; Yang, JC | 1 |
| Baltopoulo, G; Boutzouka, E; Fousteri, M; Markantonis, SL; Markou, N; Tsigou, E | 1 |
| Jain, M; Jajoo, M; Kumar, V; Kumari, S; Manchanda, V | 1 |
| Cho, E; Davidson, AG; Lillquist, YP | 1 |
| Bonomo, RA; Endimiani, A; Fraser, TG; Hall, GS; Neuner, EA; Sekeres, J; Shrestha, NK; van Duin, D; Yeh, JY | 1 |
| Berenguer, N; Grau, S; Horcajada, JP; Luque, S; Montero, MM; Salas, E; Sorlí, L | 1 |
| Couet, W; Frasca, D; Gobin, P; Grégoire, N; Marchand, S; Mimoz, O; Saulnier, PJ | 1 |
| Forrest, A; Garonzik, SM; Jacob, J; Li, J; Nation, RL; Paterson, DL; Shoham, S; Silveira, FP; Thamlikitkul, V | 1 |
| Celik, IH; Demirel, G; Dilmen, U; Erdeve, O; Oguz, SS | 1 |
| Bergen, PJ; Li, J; Nation, RL | 1 |
| Chen, CC; Chen, CH; Chiang, SR; Chuang, YC; Ko, WC; Lee, NY; Shieh, JM; Tang, HJ | 1 |
| Docobo-Pérez, F; Domínguez-Herrera, J; López-Rojas, R; Nordmann, P; Pachón, J; Poirel, L; Smani, Y | 1 |
| Brienza, N; Bruno, F; Coppolecchia, S; Dalfino, L; Miragliotta, G; Monno, R; Mosca, A; Puntillo, F; Spada, ML | 1 |
| Lipman, J; Roberts, JA | 1 |
| Boyd, BJ; Li, J; Nation, RL; Prankerd, RJ; Wallace, SJ | 1 |
| Accetta, G; Cusato, M; Del Gaudio, A; Imberti, R; Iotti, GA; Marinò, V; Procaccio, F; Regazzi, M | 1 |
| Angyalosi, G; Balp, MM; Capkun-Niggli, G; Doering, G; Higashi, K; Jansen, JP; Littlewood, KJ; Tiddens, HA | 1 |
| Fiegel, J; Sommerfeld Ross, S | 1 |
| Baltopoulos, G; Boutzouka, E; Fousteri, M; Hroni, D; Markantonis, SL; Markou, N; Zidianakis, B | 1 |
| Athanassa, ZE; Baltopoulos, GJ; Boutzouka, EG; Fousteri, MZ; Markantonis, SL; Myrianthefs, PM; Tsakris, A | 1 |
| Andersen, R; Barber, M; Howard, R; Kozar, MP; VanBrakle, R; Waterman, P; Weintrob, AC; Wortmann, G | 1 |
| de Boer, AH; Hagedoorn, P; Woolhouse, R; Wynn, E | 1 |
| Ampofo, K; Sherwin, CM; Spigarelli, MG; Stockmann, C; Waters, CD; Young, DC; Zobell, JT | 1 |
| Blumer, J; Fuchs, EJ; Gray, W; Griffiss, JM; Healan, AM; Salata, RA | 1 |
| Döring, G; Goldman, MH; Haliburn, C; Schuster, A | 1 |
| Armaganidis, A; Cars, O; Friberg, LE; Giamarellou, H; Karaiskos, I; Karvanen, M; Papadomichelakis, E; Paramythiotou, E; Plachouras, D; Tsangaris, I | 1 |
| Fernández, AB; Pérez, M; Soto, L | 1 |
| Fousteri, M; Karvouniaris, M; Makris, D; Markantonis, SL; Panidis, D; Zakynthinos, E; Ziaka, M; Zygoulis, P | 1 |
| Calero, C; Dapena, FJ; Lopez-Campos, JL; Quintana-Gallego, E | 1 |
| Aanaes, K; Alanin, M; Hjuler, T; Johansen, HK; Skov, M; von Buchwald, C | 1 |
| Han, S; Hong, T; Jeon, S; Lee, J; Song, W; Woo, H; Yim, DS | 1 |
| Gogtay, JA; Gogtay, NJ; Gore, MS; Gupta, V; Jadhav, SP; Kadam, PP; Karnik, ND; Mehta, PR; Naidu, RK; Namjoshi, RD; Sridharan, K; Surase, PV; Thatte, UM | 1 |
| Chen, G; He, H; Jacob, J; Lee, HJ; Li, J; Li, JC; Nation, RL; Roberts, K; Thompson, PE; Tsuji, BT; Velkov, T | 1 |
| Alvarez-Lerma, F; Grau, S; Horcajada, JP; Luque, S; Segura, C; Sorlí, L; Valle, M | 1 |
| Akajagbor, DS; Charurat, ME; Dakum, P; Gilliam, BL; Shere-Wolfe, KD; Wilson, SL | 1 |
| Kamin, W; Krämer, I; Wollstadt, A | 1 |
| Akter, J; Deris, ZZ; Li, J; Nation, RL; Roberts, KD; Sivanesan, S; Thompson, PE; Velkov, T | 1 |
| Chen, G; Jitmuang, A; Koomanachai, P; Landersdorfer, CB; Lee, HJ; Li, J; Nation, RL; Sritippayawan, S; Thamlikitkul, V; Wasuwattakul, S | 2 |
| Biancone, L; Bua, RO; Carignano, P; Leporati, M; Mariano, F; Stella, M; Vincenti, M | 1 |
| Albarrak, AM; Alfahad, WA; Omrani, AS | 1 |
| Cantrell, A; Carroll, C; Harnan, S; Mildred, M; Tappenden, P; Uttley, L | 1 |
| Brownlee, K; Cantrell, A; Harnan, S; Tappenden, P; Taylor, C; Uttley, L; Walshaw, M | 1 |
| Brownlee, K; Harnan, S; Mildred, M; Tappenden, P; Taylor, C; Uttley, L; Walshaw, M | 1 |
| Clark, P; Knight, H; Nolan, K | 1 |
| Kamei, LK; Lopes, CK; Rigatto, MH; Rocha, JL; Tuon, FF; Zavascki, AP | 1 |
| Conole, D; Keating, GM | 1 |
| Clark, D; Dooley, MJ; George, J; Li, J; McIntosh, MP; Nation, RL; Patel, K; Poole, S; Porter, CJ; Williams, E; Wilson, JW; Yapa, SWS | 1 |
| Cottreau, JM; Figueroa, DA; Hu, M; Lee, Y; McDaneld, PM; Musick, WL; Phe, K; Prasad, N; Tam, VH; Yin, T | 1 |
| Zavascki, AP | 1 |
| Fujita, K; Goto, H; Hattori, T; Ito, N; Koike, N; Kumakura, S; Kuroda, M; Matsumoto, T; Miyake, T; Tajima, K; Yamaguchi, T | 1 |
| Fiel, SB | 1 |
| Tappenden, P; Uttley, L | 1 |
| Pike, M; Saltiel, E | 1 |
| Boisson, M; Couet, W; Gobin, P; Grégoire, N; Jacobs, M; Marchand, S; Mimoz, O | 1 |
| Balayn, D; Chatelier, D; Comets, E; Couet, W; Gauzit, R; Gobin, P; Grégoire, N; Lasocki, S; Marchand, S; Mégarbane, B; Mimoz, O | 1 |
| Buclin, T; Corti, N; Couet, W; Csajka, C; Decosterd, LA; Gardiol, C; Guidi, M; Marchetti, O; Mercier, T; Tissot, F; Wehrli, S | 1 |
| Chen, FL; Hsieh, TC; Jean, SS; Lee, WS; Ou, TY | 1 |
| Asensio, VJ; Bachiller, D; Esquisabel, A; Gainza, E; Moreno-Sastre, M; Pastor, M; Pedraz, JL; Pozo, AD; Sans, E; Viñas, M | 1 |
| Attie, S; Bonelli, I; Maskin, LP; Rodríguez, PO; Setten, M; Stryjewski, ME; Valentini, R | 1 |
| Dasenbrook, EC; Konstan, MW; VanDevanter, DR | 1 |
| Birkhoff, W; Dijkmans, AC; Kamerling, IM; Ortiz-Zacarías, NV; Touw, DJ; van Nieuwkoop, C; Verbrugh, HA; Wilms, EB | 1 |
| Heil, EL; Lowery, AV; Nicolau, DP; Thom, KA | 1 |
| Chirla, D; Giri, SR; Kumar, PP; Panigrahy, N; Shaikh, FA | 1 |
| Bulut, C; Demirelli, M; Erdinc, S; Ertem, G; Temocin, F; Tulek, N | 1 |
| Chae, SL; Chung, JW; Huh, HJ; Jeong, YJ; Kim, KS; Kwon, KH; Oh, JY; Park, SY; Shin, SJ; Yoon, YS | 1 |
| Abdulla, A; de Vries Schultink, AH; Koch, BC; van Leeuwen, RW | 1 |
| Malacarne, P; Sbrana, F; Tascini, C; Viaggi, B | 1 |
| Apostolides, Z; Buys, A; Nardell, EA; Stoltz, AC; van Breda, SV | 1 |
| Bouchene, S; Cabrera, M; Couet, W; de Monte, M; Diot, P; Gobin, P; Grégoire, N; Guilleminault, L; Marchand, S; Montharu, J; Vecellio, L | 1 |
| Chokephaibulkit, K; Imberti, R; Lertpichaluk, P; Nakwan, N; Regazzi, M; Villani, P | 1 |
| Aslan, E; Aydemir, H; Deveci, O; Duygu, F; Gul, S; Kacmaz, B; Kuscu, F; Ozturk, DB; Yaman, F | 1 |
| Baziaka, F; Friberg, LE; Galani, L; Giamarellou, H; Ioannidis, K; Karaiskos, I; Kostakou, E; Koutsoukou, A; Paskalis, C; Pontikis, K; Tsagkari, V | 1 |
| Friberg, LE; Kristoffersson, AN; Nyberg, J | 1 |
| Collie, D; Doherty, C; Glendinning, L; Govan, J; McLachlan, G; Tennant, P; Thornton, E; Wright, S | 1 |
| Balayn, D; Couet, W; Gobin, P; Grégoire, N; Jacobs, M; Marchand, S; Mégarbane, B; Mimoz, O | 1 |
| Abril-López de Medrano, V; Gimeno-Cardona, C; Ortega-García, MP | 1 |
| Chatterjee, M; Dutta, A; Majumdar, R; Mitra, P; Nag, SS | 1 |
| Balducci, AG; Buttini, F; Colombo, G; Di Cuia, M; Elviri, L; Rossi, A; Rossi, I; Sonvico, F | 1 |
| Cardoso, DE; Carrilho, CM; Falci, DR; Levin, AS; Lopes, NT; Oliveira, MS; Perdigão-Neto, LV; Rigatto, MH; Tanita, MT; Tuon, FF; Zavascki, AP | 1 |
| Abdellatif, S; Ben Lakhal, S; Bouzidi, M; Daly, F; Mahjoub, K; Mannai, R; Nasri, R; Oueslati, M; Trifi, A | 1 |
| Jeong, ES; Jeong, J; Kim, DH; Kim, G; Kim, HS; Kim, YB; Moon, KS; Oh, JH; Shin, JG | 1 |
| Agrawal, D; Chatterjee, S | 1 |
| Chokephaibulkit, K; Imberti, R; Nakwan, N; Regazzi, M; Usaha, S; Villani, P | 1 |
| Assous, MV; Ben-Chetrit, E; Katz, DE; Marchaim, D; Wiener-Well, Y; Yinnon, A | 1 |
| Bonomo, RA; Smith, TC; Watkins, RR | 1 |
| Aitken, SL; Guervil, DJ; Lam, WM; Luce, AM; Musgrove, RJ; Phe, K; Shields, RK; Tam, VH; Tverdek, FP | 1 |
| Baietto, L; Corcione, S; D'Avolio, A; De Rosa, FG; Di Perri, G; Malvasio, V; Stella, M | 1 |
| Bachiller, D; Esquisabel, A; Moreno-Sastre, M; Pastor, M; Pedraz, JL; Sans, E; Viñas, M | 1 |
| Apparuit, M; Bihan, K; Enjalbert, M; Funck-Brentano, C; Langeron, O; Lu, Q; Rouby, JJ; Zahr, N | 1 |
| Bischof, RJ; Landersdorfer, CB; Li, J; Lieu, LT; McIntosh, MP; Meeusen, EN; Nation, RL; Nguyen, G; Nguyen, TH | 1 |
| Dishon Benattar, Y; Leibovici, L; Paul, M; Yahav, D | 1 |
| Nation, RL; Zavascki, AP | 1 |
| Anabtawi, N; Nazer, LH | 1 |
| Alvarez-Lerma, F; Benito, N; Campillo, N; Esteve, E; Grau, S; Herrera, S; Horcajada, JP; Luque, S; Montero, M; Segura, C; Sorlí, L | 1 |
| Hickerson, WL; Hill, DM; Wilkinson, RE | 1 |
| Ahmed, MU; Azad, MAK; Chan, K; Li, J; Lin, YW; Nowell, CJ; Velkov, T; Yun, B; Zhou, F; Zhou, QT | 1 |
| Hardaker, LEA; Hatley, RHM; Metcalf, AP | 1 |
| Boisson, M; Cormier, M; Couet, W; Gobin, P; Grégoire, N; Marchand, S; Mimoz, O | 1 |
| Cao, W; Debonnett, L; Greenwood, J; Hamed, K; Mastoridis, P; Nash, EF; Schwarz, C; Sommerwerck, U; Tamm, M | 1 |
| Blanco, AR; D'Angelo, V; D'Arrigo, M; Marino, A; Mazzone, MG; Nostro, A | 1 |
| Arbelot, C; Becquemin, MH; Bertholon, JF; Bihan, K; Langeron, O; Lu, Q; Lu, X; Monsel, A; Rouby, JJ; Vezinet, C; Zahr, N | 1 |
| Bouchène, S; Couet, W; Grégoire, N; Henri, J; Laroche, J; Laurentie, M; Manceau, J; Rolland, JG; Viel, A | 1 |
| Al-Zakwani, IS; Gaifer, Z; Hassan, MM | 1 |
| Aydoğdu, M; Bacakoğlu, F; Berk Takır, H; Çeltik, A; Ergan, B; Ergün, R; Gaygısız, Ü; Gürsel, G; Gürün Kaya, A; Güven, P; Kalamanoğlu Balcı, M; Korkmaz Ekren, P; Saltürk, C; Sayıner, A; Töreyin, ZN; Ulubay, G; Uluer, H; Yalçın, A | 1 |
| Björkman, S; Bouchene, S; Couet, W; Friberg, LE; Gobin, P; Grégoire, N; Karlsson, MO; Lamarche, I; Marchand, S | 1 |
| Couet, W; Fron, D; Grégoire, N; Loiez, C; Magréault, S; Marchand, S; Nectoux, E; Petyt, C; Senneville, E | 1 |
| Koen, N; Loots, DT; van Breda, SV | 1 |
| Aslan, T; Ceylan, B; Ercan, Ç; Kılıç, Ü; Ozansoy, M; Yıldız, P; Yozgat, Y | 1 |
| Hsieh, TC; Hsu, CW; Hsueh, PR; Jean, SS; Lam, C; Lee, WS | 1 |
| Buclin, T; Corti, N; Decosterd, L; Leuppi-Taegtmeyer, AB; Mueller, NJ; Osthoff, M | 1 |
| Baira, E; Dagla, I; Gikas, E; Karkoula, E; Tsarbopoulos, A | 1 |
| Arenzana Seisdedos, Á; Cantón-Bulnes, ML; Garnacho-Montero, J; Hurtado Martínez, Á; López-Cerero, L; Merino-Bohorquez, V | 1 |
| Chor, YK; Landersdorfer, CB; Li, J; Nation, RL; Ngu, SJ; Ooi, MH | 1 |
| Cogen, JD; Goss, CH; Nichols, DP; Nick, JA; Nick, SE; Russell, R; Saavedra, MT; Somayaji, R; Taylor-Cousar, JL | 1 |
| Aguirre, JJ; Bachiller, D; Basas, J; Esquisabel, A; Fleischer, A; Gainza, E; Gainza, G; Gavaldà, J; Gomis, X; Gutiérrez, FB; Hernandez, RM; Igartua, M; Moreno-Sastre, M; Palomino, E; Pastor, M; Pedraz, JL; Vairo, C | 1 |
| Barco, S; Cangemi, G; Castagnola, E; Mesini, A; Tripodi, G | 1 |
| Altay, A; Buttini, F; Colombo, G; Kozáková, J; Mašková, L; Quarta, E; Rossi, A; Sonvico, F; Ždímal, V | 1 |
| Benítez-Cano, A; Bermejo, S; Campillo, N; Carazo, J; de Antonio-Cuscó, M; Grau, S; Horcajada, JP; Luque, S; Ramos, I; Samsó, E; Sorlí, L | 1 |
| Eiam-Ong, S; Praditpornsilpa, K; Srisawat, N; Susantitaphong, P; Thammathiwat, T; Tiranathanagul, K | 1 |
| Fu, L; Li, H; Li, X; Liu, J; Luo, S; Wan, Z; Wang, Y; Wu, X; Xie, X; Zhao, Z | 1 |
| Murali, S; Pillai, AV; Ramachandran, R | 1 |
| Abad, CLR; Li, KL | 1 |
| Mahendran, M; Ray, A; Tabish, M; Vikram, NK | 1 |
| Abza, GB; Annaert, P; De Vocht, T; Deferm, N; Gijsen, M; Nauwelaerts, N; Qi, B; Spriet, I; Van Brantegem, P; Wauters, J | 1 |
| Almirante, B; Basas, J; Gainza, E; Gainza, G; Gavaldà, J; Gomis, X; Hernandez, RM; Igartua, M; Palau, M; Pastor, M; Vairo, C | 1 |
| Balachandran, S; Dipu, TS; Edathadathil, F; Kaye, KS; Menon, VP; Mohamed, Z; Moni, M; Patel, P; Patel, T; Prabhu, BP; Prasanna, P; Singh, SK; Sudhir, AS | 1 |
| Bilton, D; Caine, N; Charman, SC; Kaplan, S; Lee, A | 1 |
| Kaplan, S; Madison, T; Patino, O; Rainville, C | 1 |
| Dagla, I; Gikas, E; Tsarbopoulos, A | 2 |
| Alaminos, M; Bermejo-Casares, F; Campos, F; Carriel, V; Chato-Astrain, I; Chato-Astrain, J; Gainza, G; García-García, ÓD; Garzón, I; Oruezabal, RI; Ponce-Polo, Á; Sánchez-Porras, D; Vairo, C; Villar-Vidal, M; Villullas, S | 1 |
| Bhati, RK; Meshram, GG; Ram, K; Sheikh, S; Suri, JC; Tripathi, CD | 1 |
| Bergen, PJ; Hua, X; Karaiskos, I; Kaye, KS; Li, C; Li, J; Pogue, JM; Sharma, VS; Song, J; Tsuji, BT; Zhu, Y | 1 |
| Abdelmajed, MA; Attia, TZ; Badr El-Din, KM; Omar, MA | 1 |
| Bradbury, P; Kassiou, M; Ong, HX; Pozzoli, M; Reekie, TA; Robinson, PD; Sheikh, Z; Traini, D; Young, PM | 1 |
| Blau, H; Kadosh, D; Kalamaro, V; Landau, E; Mantin, H; Mei-Zahav, M; Mussaffi, H; Prais, D; Quittner, A; Taizi, T | 1 |
| Crass, RL; Fitzgerald, LJ; Han, MK; Jia, S; Lenhan, BE; Lipp, MA; Patel, TS; Simon, RH | 1 |
| Ashok, N; Jayakumar, R; Kumar, VA; Menon, RR; Pillai, AV; Pradeep, A; Priya, V | 1 |
| Exposito-Ruiz, M; García-Fumero, R; Hidalgo-Tenorio, C; Jiménez-Morales, A; Pasquau-Liaño, J; Sadyrbaeva-Dolgova, S | 1 |
20 review(s) available for colistimethate sodium and colistin
| Article | Year |
|---|---|
Polymyxin B, colistin, and sodium colistimethate.
Topics: Bacteria; Bacterial Infections; Colistin; Humans; Kinetics; Polymyxin B; Polymyxins | 1982 |
Contact dermatitis due to sodium colistimethate.
Topics: Anti-Bacterial Agents; Child, Preschool; Colistin; Dermatitis, Contact; Drug Eruptions; Eye Infections; Eye, Artificial; Facial Dermatoses; Female; Humans; Ophthalmic Solutions; Patch Tests | 1998 |
Difficulty in assaying colistin methanesulphonate.
Topics: Animals; Colistin; Cystic Fibrosis; Humans | 2005 |
Acinetobacter baumannii: an emerging multidrug-resistant pathogen in critical care.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Arizona; Centers for Disease Control and Prevention, U.S.; Colistin; Communicable Diseases, Emerging; Critical Care; Disease Outbreaks; Disease Reservoirs; Drug Resistance, Multiple, Bacterial; Environmental Microbiology; Equipment Contamination; Genes, Bacterial; Genes, MDR; Humans; Infection Control; Minocycline; Nursing Staff, Hospital; Risk Factors; Tigecycline; Total Quality Management; United States | 2008 |
Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing.
Topics: Anti-Bacterial Agents; Colistin; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans | 2010 |
[Shedding light on the use of colistin: still gaps to be filled].
Topics: Animals; Anti-Bacterial Agents; Clinical Trials as Topic; Colistin; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Kidney Tubular Necrosis, Acute; Prospective Studies; Retrospective Studies | 2011 |
Dosing of colistin-back to basic PK/PD.
Topics: Animals; Anti-Bacterial Agents; Colistin; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Prodrugs | 2011 |
A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis.
Topics: Administration, Inhalation; Adolescent; Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Load; Bayes Theorem; Biological Availability; Chronic Disease; Colistin; Cystic Fibrosis; Disease Progression; Female; Forced Expiratory Volume; Humans; Information Services; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Tobramycin; Treatment Outcome | 2012 |
Colistimethate sodium powder and tobramycin powder for inhalation for the treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis: systematic review and economic model.
Topics: Administration, Inhalation; Child; Colistin; Cost-Benefit Analysis; Cystic Fibrosis; Disease Progression; Humans; Outcome Assessment, Health Care; Pseudomonas aeruginosa; Pseudomonas Infections; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Therapeutic Equivalency; Tobramycin; United Kingdom | 2013 |
Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Colistin; Cystic Fibrosis; Disease Progression; Dry Powder Inhalers; Evidence-Based Medicine; Forced Expiratory Volume; Humans; Lung; Powders; Pseudomonas aeruginosa; Pseudomonas Infections; Research Design; Time Factors; Tobramycin; Treatment Outcome | 2013 |
Colistimethate sodium dry powder for inhalation: a review of its use in the treatment of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Topics: Chronic Disease; Colistin; Cystic Fibrosis; Drug Resistance, Bacterial; Dry Powder Inhalers; Humans; Lung; Pseudomonas aeruginosa; Pseudomonas Infections | 2014 |
Aerosolized antibiotics in cystic fibrosis: an update.
Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Aztreonam; Colistin; Cystic Fibrosis; Equipment Design; Humans; Levofloxacin; Nebulizers and Vaporizers; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Tobramycin | 2014 |
Dry powder inhalers in cystic fibrosis: same old drugs but different benefits?
Topics: Administration, Inhalation; Anti-Bacterial Agents; Colistin; Cost-Benefit Analysis; Cystic Fibrosis; Dry Powder Inhalers; Humans; Medication Adherence; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome | 2014 |
Colistin- and polymyxin-induced nephrotoxicity: focus on literature utilizing the RIFLE classification scheme of acute kidney injury.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Colistin; Humans; Polymyxin B | 2014 |
Colistin: Revival of an Old Polymyxin Antibiotic.
Topics: Anti-Bacterial Agents; Colistin; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests | 2015 |
Ventilator-associated pneumonia caused by colistin-resistant KPC-producing Klebsiella pneumoniae: a case report and literature review.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Calcitonin; Calcitonin Gene-Related Peptide; Colistin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Equipment Contamination; Fosfomycin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Minocycline; Pneumonia, Bacterial; Protein Precursors; Tigecycline; Treatment Outcome; Ventilators, Mechanical | 2015 |
Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Bacterial Infections; Biological Transport; Clinical Trials as Topic; Colistin; Humans; Kidney; Mice; Polymyxin B; Prodrugs; Rats; Survival Analysis | 2017 |
Optimizing colistin dosing: Is a loading dose necessary?
Topics: Anti-Bacterial Agents; Colistin; Critical Illness; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Prodrugs; Treatment Outcome | 2017 |
Analytical methodologies used for the determination of colistin in biological fluids. Is it still a challenge?
Topics: Animals; Anti-Bacterial Agents; Biological Products; Chemical Fractionation; Chromatography; Colistin; Humans; Mass Spectrometry; Paenibacillus polymyxa; Prodrugs | 2019 |
Potential pitfalls in LC-MS/MS quantification of colistin for therapeutic drug monitoring of patients treated with colistimethate.
Topics: Chromatography, Liquid; Colistin; Drug Monitoring; Humans; Tandem Mass Spectrometry | 2019 |
11 trial(s) available for colistimethate sodium and colistin
| Article | Year |
|---|---|
Combination of pipemidic acid, colistin sodium methanesulfonate and nystatin may be less effective than nystatin alone for prevention of infection during chemotherapy-induced granulocytopenia in acute leukemia.
Topics: Acute Disease; Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Colistin; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Leukemia; Middle Aged; Nicotinic Acids; Nystatin; Pipemidic Acid; Pneumonia; Random Allocation | 1989 |
Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.
Topics: Adult; Aged; Aged, 80 and over; Chromatography, Liquid; Colistin; Critical Illness; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Male; Middle Aged; Tandem Mass Spectrometry | 2009 |
Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Colistin; Cross Infection; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Treatment Outcome | 2010 |
Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Colistin; Critical Illness; Female; Humans; Male; Middle Aged; Young Adult | 2011 |
Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study.
Topics: Administration, Inhalation; Adult; Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Colistin; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Male; Powders; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome; Young Adult | 2013 |
[Nebulized colistin versus tobramycin in the treatment of chronic Pseudomonas colonization in cystic fibrosis patients].
Topics: Administration, Inhalation; Body Mass Index; Child; Child, Preschool; Colistin; Cross-Over Studies; Cystic Fibrosis; Drug Resistance, Bacterial; Female; Forced Expiratory Volume; Humans; Lung; Male; Nebulizers and Vaporizers; Patient Satisfaction; Pseudomonas aeruginosa; Sputum; Surveys and Questionnaires; Tobramycin; Treatment Outcome | 2014 |
Pharmacokinetics of colistin in critically ill patients with multidrug-resistant Gram-negative bacilli infection.
Topics: Acinetobacter; Adolescent; Adult; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; India; Infusions, Intravenous; Intensive Care Units; Kidney; Klebsiella pneumoniae; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pseudomonas; Renal Insufficiency; Tertiary Care Centers; Young Adult | 2013 |
Pulmonary and systemic pharmacokinetics of inhaled and intravenous colistin methanesulfonate in cystic fibrosis patients: targeting advantage of inhalational administration.
Topics: Administration, Inhalation; Aged; Aged, 80 and over; Anti-Bacterial Agents; Colistin; Cystic Fibrosis; Female; Humans; Lung; Male; Middle Aged; Sputum | 2014 |
Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection.
Topics: Administration, Inhalation; Adolescent; Adult; Anti-Bacterial Agents; Child; Colistin; Cross-Over Studies; Cystic Fibrosis; Equipment Contamination; Equipment Design; Europe; Female; Forced Expiratory Volume; Humans; Lung; Male; Nebulizers and Vaporizers; Patient Satisfaction; Powders; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Time Factors; Tobramycin; Treatment Outcome; Young Adult | 2017 |
Multicenter Population Pharmacokinetic Study of Colistimethate Sodium and Colistin Dosed as in Normal Renal Function in Patients on Continuous Renal Replacement Therapy.
Topics: Adult; Aged; Anti-Bacterial Agents; Chromatography, Liquid; Colistin; Continuous Renal Replacement Therapy; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Mass Spectrometry; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections | 2019 |
Population Pharmacokinetics of Intravenous Colistin in Pediatric Patients: Implications for the Selection of Dosage Regimens.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Child; Child, Preschool; Colistin; Female; Humans; Infant; Male | 2019 |
149 other study(ies) available for colistimethate sodium and colistin
| Article | Year |
|---|---|
[Elimination of polypeptide antibiotics (colistin and bacitracin) in the milk after intramuscular or intramammary administration].
Topics: Animals; Bacitracin; Cattle; Colistin; Drug Residues; Female; Injections, Intramuscular; Mammary Glands, Animal; Milk | 1987 |
Selective pigment medium for Streptococcus agalactiae.
Topics: Adult; Agar; Animals; Blood; Caseins; Colistin; Culture Media; Female; Humans; Infant, Newborn; Nalidixic Acid; Peptide Fragments; Pigments, Biological; Sheep; Starch; Streptococcus agalactiae; Zea mays | 1983 |
Rosaramicin: in-vitro activity against common bacterial isolates.
Topics: Bacteria; Colistin; Drug Synergism; Drug Therapy, Combination; Leucomycins; Microbial Sensitivity Tests | 1981 |
Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Anti-Bacterial Agents; Brain Diseases; Carbapenems; Central Nervous System Bacterial Infections; Cerebral Ventricles; Colistin; Drug Resistance, Microbial; Encephalitis; Female; Humans; Injections, Intraventricular; Male; Middle Aged; Treatment Outcome | 1999 |
In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
Topics: Anti-Bacterial Agents; Colistin; Cystic Fibrosis; Humans; Kinetics; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Time Factors | 2001 |
Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Colistin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Synergism; Humans; Microbial Sensitivity Tests; Rifampin | 2001 |
Simple method for assaying colistin methanesulfonate in plasma and urine using high-performance liquid chromatography.
Topics: Animals; Chromatography, High Pressure Liquid; Colistin; Rats; Reproducibility of Results; Sensitivity and Specificity | 2002 |
Stability of colistin and colistin methanesulfonate in aqueous media and plasma as determined by high-performance liquid chromatography.
Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Colistin; Culture Media; Drug Stability; Humans; Solutions | 2003 |
Colistimethate sodium: a clinical study.
Topics: Biomedical Research; Colistin; Humans; Urinary Tract Infections | 1963 |
A REPORT ON THE USE OF COLISTIMETHATE SODIUM IN A GENERAL HOSPITAL.
Topics: Colistin; Enterobacter aerogenes; Enterococcus faecalis; Escherichia coli Infections; Hospitals, General; Humans; Proteus Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Streptococcal Infections; Urinary Tract Infections | 1963 |
EFFICACY OF COLISTIMETHATE SODIUM IN TREATMENT OF PSEUDOMONAS INFECTION.
Topics: Colistin; Humans; Injections; Injections, Intramuscular; Keratoconjunctivitis; Neomycin; Ophthalmic Solutions; Penicillins; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections; Streptomycin | 1963 |
A COMPARISON OF THE BEHAVIOR OF COLISTIMETHATE SODIUM, KANAMYCIN SULFATE, AND NALIDIXIC ACID OBSERVED IN CLINICAL STUDIES.
Topics: Anti-Bacterial Agents; Biomedical Research; Colistin; Drug Therapy; Kanamycin; Nalidixic Acid; Toxicology | 1964 |
INTRAVENOUS ADMINISTRATION OF SODIUM COLISTIMETHATE.
Topics: Administration, Intravenous; Blood Chemical Analysis; Colistin; Creatine; Creatinine; Humans; Injections, Intramuscular; Injections, Intravenous; Kidney Function Tests; Nitrogen; Pharmacology; Pneumonia; Probenecid; Pseudomonas Infections; Pyelonephritis; Sodium; Urea | 1964 |
[EXPERIENCES WITH SODIUM COLISTIN METHANESULFONATE IN BACILLARY DYSENTERY].
Topics: Adolescent; Anti-Bacterial Agents; Bacillus; Child; Chloramphenicol; Colistin; Drug Therapy; Dysentery; Dysentery, Bacillary; Geriatrics; Humans; Kanamycin; Mesylates; Sodium; Streptomycin; Tetracycline | 1964 |
TREATMENT OF INFECTIONS WITH COLISTIMETHATE SODIUM (COLY-MYCIN).
Topics: Colistin; Drug Therapy; Enterobacter; Escherichia coli; Escherichia coli Infections; Geriatrics; Humans; Proteus; Pseudomonas Infections; Respiratory Tract Infections; Toxicology; Urinary Tract Infections | 1965 |
Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Colistin; Cystic Fibrosis; Drug Stability; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged | 2003 |
Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Chromatography, High Pressure Liquid; Colistin; Half-Life; Injections, Intravenous; Rats | 2004 |
[Colistimethate: an old antibiotic revived by new scientific evidence].
Topics: Colistin; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans | 2005 |
Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration.
Topics: Colistin; Critical Illness; Female; Hemodiafiltration; Humans; Middle Aged; Pseudomonas aeruginosa | 2005 |
Colistin methanesulfonate against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Ceftazidime; Colistin; Colony Count, Microbial; Drug Combinations; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests | 2007 |
Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Biofilms; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Rifampin | 2007 |
Compounded colistimethate as possible cause of fatal acute respiratory distress syndrome.
Topics: Administration, Inhalation; Adult; Anti-Bacterial Agents; Colistin; Cystic Fibrosis; Drug Compounding; Fatal Outcome; Female; Humans; Nebulizers and Vaporizers; Prodrugs; Pseudomonas Infections; Respiratory Distress Syndrome | 2007 |
Potential for underdosing and emergence of resistance in Acinetobacter baumannii during treatment with colistin.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Burns; Colistin; Drug Resistance, Bacterial; Female; Humans; Microbial Sensitivity Tests; Mutation | 2008 |
Multidrug-resistant Acinetobacter baumannii pneumonia in lung transplant recipients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Infective Agents; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Lung Transplantation; Male; Minocycline; Pneumonia; Risk Factors; Tigecycline; Treatment Outcome | 2008 |
Intravenous colistimethate for multidrug-resistant Gram-negative bacteria.
Topics: Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans | 2008 |
Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patients.
Topics: Anti-Bacterial Agents; Chemistry, Pharmaceutical; Colistin; Drug Stability; Drug Storage; Gram-Negative Bacterial Infections; Humans; Hydrolysis; Pharmaceutical Solutions; Solutions; Temperature | 2008 |
Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Colistin; Female; Humans; Incidence; Injections, Intravenous; Male; Renal Insufficiency; United States; Withholding Treatment; Young Adult | 2009 |
Polymyxin B and colistimethate are comparable as to efficacy and renal toxicity.
Topics: Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Colistin; Female; Humans; Kidney; Male; Middle Aged; Polymyxin B; Treatment Outcome; Young Adult | 2009 |
Colistimethate sodium therapy for multidrug-resistant isolates in pediatric patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Child; Child, Preschool; Colistin; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Female; Follow-Up Studies; Hospitals, University; Humans; Infant; Infant, Newborn; Injections, Intravenous; Intensive Care Units, Neonatal; Intensive Care Units, Pediatric; Male; Microbial Sensitivity Tests; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Statistics, Nonparametric; Treatment Outcome; Turkey | 2010 |
Self-assembly behavior of colistin and its prodrug colistin methanesulfonate: implications for solution stability and solubilization.
Topics: Anti-Bacterial Agents; Azithromycin; Colistin; Micelles; Prodrugs; Solutions; Surface-Active Agents | 2010 |
Mortality associated with Acinetobacter baumannii infections experienced by lung transplant recipients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Colistin; Humans; Imipenem; Immunosuppressive Agents; Lung Transplantation; Minocycline; Pneumonia, Bacterial; Radiography; Retrospective Studies; Tigecycline | 2010 |
A novel combination regimen for the treatment of refractory bacteremia due to multidrug-resistant Pseudomonas aeruginosa in a liver transplant recipient.
Topics: Anti-Bacterial Agents; Bacteremia; Bile Duct Diseases; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome | 2010 |
Intravenous colistimethate administration and colistin lung tissue concentrations.
Topics: Anti-Infective Agents; Colistin; Humans; Infusions, Intravenous; Lung | 2010 |
Colistin penetration in the alveolar lining fluid of critically ill patients treated with IV colistimethate sodium.
Topics: Bronchoalveolar Lavage Fluid; Colistin; Critical Illness; Humans; Injections, Intravenous; Pneumonia, Ventilator-Associated | 2011 |
Intravenous colistin administration in neonates.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteremia; Colistin; Critical Care; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacter; Female; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Infusions, Intravenous; Klebsiella pneumoniae; Male; Pseudomonas aeruginosa; Treatment Outcome | 2011 |
Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009.
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Burkholderia cepacia complex; Child; Child, Preschool; Ciprofloxacin; Cohort Studies; Colistin; Cystic Fibrosis; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Health Care Costs; Health Resources; Humans; Infant; Injections, Intravenous; Nebulizers and Vaporizers; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome | 2011 |
Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Minocycline; Prognosis; Retrospective Studies; Tigecycline; Treatment Outcome | 2011 |
Pharmacokinetics of colistin and colistimethate sodium after a single 80-mg intravenous dose of CMS in young healthy volunteers.
Topics: Adult; Age Factors; Colistin; Dosage Forms; Dose-Response Relationship, Drug; Humans; Injections, Intravenous; Male; Time Factors; Young Adult | 2011 |
Outcome of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa treated with aerosolized colistin in neonates: a retrospective chart review.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Administration, Inhalation; Anti-Bacterial Agents; Colistin; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Treatment Outcome | 2012 |
Comparative evaluation of intratracheal colistimethate sodium, imipenem, and meropenem in BALB/c mice with carbapenem-resistant Acinetobacter baumannii pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Acute Disease; Animals; Anti-Bacterial Agents; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Colistin; Cytokines; Disease Models, Animal; Drug Combinations; Drug Resistance, Bacterial; Female; Imipenem; Meropenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pneumonia, Bacterial; Stem Cells; Thienamycins | 2012 |
Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Bacterial Load; Bacterial Proteins; beta-Lactamases; Colistin; Disease Models, Animal; Drug Evaluation, Preclinical; Enterobacteriaceae Infections; Escherichia coli; Female; Klebsiella pneumoniae; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2012 |
High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Colistin; Critical Illness; Cross Infection; Female; Gram-Negative Bacterial Infections; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Sepsis; Treatment Outcome | 2012 |
Editorial commentary: Closing the loop--a colistin clinical study to confirm dosing recommendations from PK/PD modeling.
Topics: Anti-Bacterial Agents; Colistin; Cross Infection; Female; Gram-Negative Bacterial Infections; Humans; Male; Sepsis | 2012 |
Interaction of colistin and colistin methanesulfonate with liposomes: colloidal aspects and implications for formulation.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Cholesterol; Colistin; Colloids; Delayed-Action Preparations; Drug Stability; Kinetics; Lipids; Liposomes; Phosphatidylcholines; Surface Properties; Technology, Pharmaceutical | 2012 |
Pharmacokinetics of colistin in cerebrospinal fluid after intraventricular administration of colistin methanesulfonate.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Central Nervous System Bacterial Infections; Colistin; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Injections, Intraventricular; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections | 2012 |
Nutrient dispersion enhances conventional antibiotic activity against Pseudomonas aeruginosa biofilms.
Topics: Amikacin; Anti-Bacterial Agents; Biofilms; Citrates; Colistin; Culture Media; Drug Resistance, Multiple, Bacterial; Drug Synergism; Erythromycin; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Confocal; Polymyxin B; Pseudomonas aeruginosa; Sodium Citrate; Succinic Acid | 2012 |
Colistin pharmacokinetics in intensive care unit patients on continuous venovenous haemodiafiltration: an observational study.
Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Colistin; Critical Illness; Gram-Negative Bacterial Infections; Hemodiafiltration; Humans; Infusions, Intravenous; Intensive Care Units; Male; Metabolic Clearance Rate; Middle Aged; Sepsis; Serum; Time Factors | 2012 |
Pharmacokinetics of inhaled colistimethate sodium (CMS) in mechanically ventilated critically ill patients.
Topics: Acinetobacter baumannii; Administration, Inhalation; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bronchitis; Colistin; Drug Resistance, Multiple; Female; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Male; Middle Aged; Pseudomonas aeruginosa; Respiration, Artificial; Tracheitis | 2012 |
The elution of colistimethate sodium from polymethylmethacrylate and calcium phosphate cement beads.
Topics: Anti-Bacterial Agents; Bone Cements; Calcium Phosphates; Colistin; Drug Delivery Systems; Polymethyl Methacrylate | 2012 |
Computational fluid dynamics (CFD) assisted performance evaluation of the Twincer™ disposable high-dose dry powder inhaler.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Chemical Phenomena; Colistin; Computer Simulation; Disposable Equipment; Drug Delivery Systems; Dry Powder Inhalers; Equipment Design; Humans; Hydrodynamics; Materials Testing; Particle Size; Powders | 2012 |
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: IV. colistimethate sodium.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Colistin; Cystic Fibrosis; Disease Progression; Female; Humans; Male; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Young Adult | 2013 |
Stability of colistimethate sodium in aqueous solution.
Topics: Anti-Bacterial Agents; Colistin; Drug Compounding; Drug Stability; Pharmaceutical Solutions; Tandem Mass Spectrometry; Temperature; Water | 2012 |
Colistin methanesulfonate and colistin pharmacokinetics in critically ill patients receiving continuous venovenous hemodiafiltration.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Colistin; Critical Illness; Drug Administration Schedule; Drug Dosage Calculations; Female; Hemodiafiltration; Humans; Male; Microbial Sensitivity Tests; Middle Aged | 2013 |
Sudden respiratory muscle paralysis and apnea in a patient infected with multidrug-resistant Pseudomonas aeruginosa treated with intravenous colistin.
Topics: Administration, Intravenous; Aged; Anti-Bacterial Agents; Apnea; Aztreonam; Colistin; Drug Resistance, Multiple, Bacterial; Fatal Outcome; Humans; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Paralysis | 2013 |
Combined intravenous and intraventricular administration of colistin methanesulfonate in critically ill patients with central nervous system infection.
Topics: Administration, Intravenous; Adult; Anti-Bacterial Agents; Central Nervous System Infections; Colistin; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies | 2013 |
The effect of sinus surgery with intensive follow-up on pathogenic sinus bacteria in patients with cystic fibrosis.
Topics: Achromobacter denitrificans; Adolescent; Adult; Burkholderia; Burkholderia Infections; Child; Chronic Disease; Colistin; Cystic Fibrosis; Female; Follow-Up Studies; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Nasal Lavage; Paranasal Sinuses; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Rhinitis; Sinusitis; Treatment Outcome; Young Adult | 2013 |
Population pharmacokinetic analysis of colistin in burn patients.
Topics: Acinetobacter baumannii; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Biological Availability; Biotransformation; Burns; Colistin; Drug Administration Schedule; Female; Gram-Negative Bacterial Infections; Half-Life; Humans; Injections, Intravenous; Male; Middle Aged; Models, Statistical; Pseudomonas aeruginosa; Treatment Outcome | 2013 |
Pharmacokinetics of four different brands of colistimethate and formed colistin in rats.
Topics: Administration, Intravenous; Animals; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Colistin; Elements; Male; Rats; Rats, Sprague-Dawley | 2013 |
Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Colistin; Critical Illness; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Male; Microbial Sensitivity Tests; Plasma; Pneumonia, Bacterial | 2013 |
Higher incidence of acute kidney injury with intravenous colistimethate sodium compared with polymyxin B in critically ill patients at a tertiary care medical center.
Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Colistin; Critical Illness; Female; Humans; Incidence; Male; Middle Aged; Polymyxin B; Retrospective Studies; Tertiary Care Centers | 2013 |
Physicochemical compatibility of nebulizable drug admixtures containing colistimethate and tobramycin.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Colistin; Drug Combinations; Drug Incompatibility; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Nebulizers and Vaporizers; Osmolar Concentration; Pharmaceutical Solutions; Pseudomonas aeruginosa; Tobramycin | 2013 |
A secondary mode of action of polymyxins against Gram-negative bacteria involves the inhibition of NADH-quinone oxidoreductase activity.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Cell Membrane; Colistin; Escherichia coli; Gram-Negative Bacteria; Klebsiella pneumoniae; NAD; Polymyxin B; Quinone Reductases; Ubiquinone | 2014 |
Pharmacokinetics of colistin methanesulfonate and formed colistin in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis.
Topics: Anti-Bacterial Agents; Colistin; Humans; Kidney Failure, Chronic; Microbial Sensitivity Tests; Peritoneal Dialysis, Continuous Ambulatory | 2014 |
Determination by LC-MS/MS of colistins A and B in plasma and ultrafiltrate from critically ill patients undergoing continuous venovenous hemodiafiltration.
Topics: Anti-Bacterial Agents; Chromatography, Liquid; Colistin; Critical Illness; Hemodiafiltration; Humans; Limit of Detection; Mass Spectrometry; Sensitivity and Specificity | 2014 |
Uptake of higher intravenous colistin methanesulfonate dosing in hospitals in the Gulf Cooperation Council states. A Web-based survey study.
Topics: Anti-Infective Agents; Colistin; Data Collection; Dose-Response Relationship, Drug; Hospitals; Humans; Infusions, Intravenous; Internet | 2013 |
The cost effectiveness of dry powder antibiotics for the treatment of Pseudomonas aeruginosa in patients with cystic fibrosis.
Topics: Adult; Anti-Bacterial Agents; Colistin; Cost-Benefit Analysis; Cystic Fibrosis; Decision Support Techniques; Dry Powder Inhalers; Humans; Models, Economic; Pneumonia, Bacterial; Probability; Pseudomonas aeruginosa; Pseudomonas Infections; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Survival Analysis; Tobramycin; Young Adult | 2014 |
NICE guidance on colistimethate sodium and tobramycin for pseudomonas lung infection in cystic fibrosis.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Clinical Trials as Topic; Colistin; Cystic Fibrosis; Drug Monitoring; Drug Therapy, Combination; Dry Powder Inhalers; Humans; Practice Guidelines as Topic; Pseudomonas Infections; Respiratory Function Tests; Respiratory Tract Infections; State Medicine; Tobramycin; United Kingdom | 2013 |
Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Acute Kidney Injury; Anti-Bacterial Agents; Cohort Studies; Colistin; Female; Hospital Mortality; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Vancomycin | 2014 |
In vitro assessment and multicenter cohort study of comparative nephrotoxicity rates associated with colistimethate versus polymyxin B therapy.
Topics: Adult; Anti-Bacterial Agents; Cell Line; Cell Survival; Colistin; Humans; Kidney; Middle Aged; Polymyxins; Retrospective Studies | 2014 |
Polymyxins for the treatment of extensively-drug-resistant Gram-negative bacteria: from pharmacokinetics to bedside.
Topics: Anti-Bacterial Agents; Area Under Curve; Colistin; Drug Administration Schedule; Drug Dosage Calculations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Polymyxin B | 2014 |
In vivo challenging of polymyxins and levofloxacin eye drop against multidrug-resistant Pseudomonas aeruginosa keratitis.
Topics: Animals; Anti-Bacterial Agents; Colistin; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Keratitis; Levofloxacin; Male; Microbial Sensitivity Tests; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits | 2014 |
Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients.
Topics: Administration, Inhalation; Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Biotransformation; Colistin; Critical Illness; Drug Administration Schedule; Drug Dosage Calculations; Extracellular Fluid; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Half-Life; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Pneumonia, Ventilator-Associated | 2014 |
New colistin population pharmacokinetic data in critically ill patients suggesting an alternative loading dose rationale.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Biotransformation; Colistin; Critical Illness; Drug Administration Schedule; Drug Dosage Calculations; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Half-Life; Humans; Lung; Male; Microbial Sensitivity Tests; Middle Aged | 2014 |
High-throughput hydrophilic interaction chromatography coupled to tandem mass spectrometry for the optimized quantification of the anti-Gram-negatives antibiotic colistin A/B and its pro-drug colistimethate.
Topics: Calibration; Chromatography, High Pressure Liquid; Colistin; Drug Monitoring; Humans; Hydrophobic and Hydrophilic Interactions; Polymyxin B; Prodrugs; Solid Phase Extraction; Tandem Mass Spectrometry | 2014 |
Role of aerosolized colistin methanesulfonate therapy for extensively-drug-resistant Acinetobacter baumannii complex pneumonia and airway colonization.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Administration, Inhalation; Aged; Aged, 80 and over; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Pneumonia, Bacterial; Retrospective Studies; Treatment Outcome | 2016 |
Sodium colistimethate loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis.
Topics: Administration, Inhalation; Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Colistin; Cystic Fibrosis; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Lipids; Mice; Microbial Sensitivity Tests; Nanoparticles; Particle Size; Pseudomonas aeruginosa; Pseudomonas Infections; Surface Properties; Tissue Distribution | 2014 |
Inhaled colistimethate sodium in ventilator-associated tracheobronchitis due to multidrug-resistant Gram-negative bacteria.
Topics: Aged; Bronchitis; Colistin; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Respiration, Artificial; Tracheitis | 2015 |
Association between the introduction of a new cystic fibrosis inhaled antibiotic class and change in prevalence of patients receiving multiple inhaled antibiotic classes.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosols; Anti-Bacterial Agents; Aztreonam; Child; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tobramycin; Treatment Outcome; Young Adult | 2015 |
Treatment of multidrug-resistant pseudomonas aeruginosa using extended-infusion antimicrobial regimens.
Topics: Adult; Anti-Bacterial Agents; Cefepime; Cephalosporins; Colistin; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Heart-Assist Devices; Humans; Infusions, Intravenous; Metabolic Clearance Rate; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Renal Dialysis; Time Factors; Treatment Outcome | 2015 |
Safety and efficacy of intravenous colistin in children.
Topics: Acute Kidney Injury; Administration, Intravenous; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Colistin; Creatinine; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Prospective Studies; Sepsis | 2015 |
Extracorporeal clearance of colistin methanesulphonate and formed colistin in end-stage renal disease patients receiving intermittent haemodialysis: implications for dosing.
Topics: Administration, Intravenous; Adult; Aged; Anti-Bacterial Agents; Blood Chemical Analysis; Chromatography, High Pressure Liquid; Colistin; Female; Humans; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Middle Aged; Models, Statistical; Prodrugs; Renal Dialysis; Time Factors; Urinalysis | 2015 |
Incidence and Risk Factors for Colistin-Associated Nephrotoxicity.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Colistin; Creatinine; Female; Humans; Incidence; Male; Middle Aged; Prevalence; Renal Insufficiency; Retrospective Studies; Risk Factors; Urea; Young Adult | 2015 |
Colistin treatment in carbapenem-resistant Acinetobacter baumannii pneumonia patients: Incidence of nephrotoxicity and outcomes.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Administration, Intravenous; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Colistin; Female; Humans; Incidence; Male; Middle Aged; Pneumonia, Bacterial; Renal Insufficiency; Retrospective Studies; Treatment Outcome | 2015 |
Stability of colistimethate sodium in a disposable elastomeric infusion device.
Topics: Colistin; Disposable Equipment; Drug Stability; Infusion Pumps; Infusions, Intravenous | 2015 |
The antimicrobial effect of colistin methanesulfonate on Mycobacterium tuberculosis in vitro.
Topics: Antitubercular Agents; Cell Wall; Colistin; Drug Synergism; Isoniazid; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Electron, Transmission; Molecular Structure; Mycobacterium tuberculosis; Pulmonary Surfactants; Rifampin; Structure-Activity Relationship; Time Factors | 2015 |
Pharmacokinetics of Colistin Methansulphonate (CMS) and Colistin after CMS Nebulisation in Baboon Monkeys.
Topics: Aerosols; Animals; Anti-Bacterial Agents; Chromatography, Liquid; Colistin; Female; Haplorhini; Lung; Nebulizers and Vaporizers; Papio; Tandem Mass Spectrometry | 2015 |
Pulmonary and Systemic Pharmacokinetics of Colistin Following a Single Dose of Nebulized Colistimethate in Mechanically Ventilated Neonates.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Colistin; Female; Humans; Infant, Newborn; Male; Plasma; Prospective Studies; Respiration, Artificial; Time Factors; Trachea | 2015 |
Risk Factors for Colistin-Associated Acute Kidney Injury: A Multicenter Study from Turkey.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Colistin; Drug Interactions; Female; Hospitals, University; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Risk Factors; Sodium Potassium Chloride Symporter Inhibitors; Turkey; Young Adult | 2016 |
Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Chromatography, Liquid; Colistin; Creatinine; Critical Illness; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Statistical; Tandem Mass Spectrometry | 2015 |
Inter occasion variability in individual optimal design.
Topics: Animals; Anti-Bacterial Agents; Bayes Theorem; Biotransformation; Colistin; Data Interpretation, Statistical; Drug Administration Schedule; Humans; Models, Biological; Models, Statistical; Prodrugs; Reproducibility of Results; Research Design; Tissue Distribution | 2015 |
Lung Microbiota Changes Associated with Chronic Pseudomonas aeruginosa Lung Infection and the Impact of Intravenous Colistimethate Sodium.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Bronchoalveolar Lavage Fluid; Chronic Disease; Colistin; Disease Models, Animal; Female; Injections, Intravenous; Lung; Male; Microbiota; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Sheep, Domestic | 2015 |
Population Pharmacokinetics of Colistin Methanesulfonate and Colistin in Critically Ill Patients with Acute Renal Failure Requiring Intermittent Hemodialysis.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Colistin; Critical Illness; Drug Administration Schedule; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Lung; Male; Microbial Sensitivity Tests; Middle Aged; Renal Dialysis; Respiratory Tract Infections | 2016 |
[Changes in the dosing of colistimethate sodium in critically ill patients].
Topics: Anti-Bacterial Agents; Bacterial Infections; Colistin; Critical Care; Critical Illness; Drug Resistance, Multiple, Bacterial; Humans | 2016 |
Intravenous Colistimethate Sodium in Neonatal Sepsis.
Topics: Administration, Intravenous; Colistin; Humans; Infant, Newborn; Neonatal Sepsis; Sepsis | 2016 |
Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients.
Topics: Anti-Bacterial Agents; Bacterial Infections; Colistin; Cystic Fibrosis; Humans; Lung Diseases; Nebulizers and Vaporizers; Solutions | 2016 |
Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B.
Topics: Acute Kidney Injury; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Weight; Colistin; Drug Administration Schedule; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Intraabdominal Infections; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Polymyxin B; Prospective Studies; Respiratory Tract Infections; Risk Factors; Survival Analysis | 2016 |
Efficacy and Toxicity of High-Dose Colistin in Multidrug-Resistant Gram-Negative Bacilli Infections: A Comparative Study of a Matched Series.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Prospective Studies; Severity of Illness Index | 2016 |
Characterization of urinary metabolites as biomarkers of colistin-induced nephrotoxicity in rats by a liquid chromatography/mass spectrometry-based metabolomics approach.
Topics: Amino Acids; Animals; Anti-Bacterial Agents; Biomarkers; Chromatography, High Pressure Liquid; Colistin; Creatinine; Kidney Diseases; Male; Metabolomics; Multivariate Analysis; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Tissue Distribution | 2016 |
Multi-drug resistant Pseudomonas aeruginosa keratitis and its effective treatment with topical colistimethate.
Topics: Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Child; Colistin; Corneal Ulcer; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Visual Acuity | 2016 |
Pharmacokinetics of Colistin Following a Single Dose of Intravenous Colistimethate Sodium in Critically Ill Neonates.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Bacteremia; Colistin; Critical Illness; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male; Pneumonia, Bacterial; Prospective Studies | 2016 |
Ten years with colistin: a retrospective case series.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Colistin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Hospitalization; Humans; Male; Microbial Sensitivity Tests; Respiratory Tract Infections; Retrospective Studies; Urinary Tract Infections | 2016 |
On the path to untreatable infections: colistin use in agriculture and the end of 'last resort' antibiotics.
Topics: Agriculture; Animal Husbandry; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; European Union; Humans | 2016 |
Predicting the risk of nephrotoxicity in patients receiving colistimethate sodium: a multicentre, retrospective, cohort study.
Topics: Academic Medical Centers; Acute Kidney Injury; Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Colistin; Decision Support Techniques; Female; Humans; Male; Middle Aged; Models, Theoretical; Retrospective Studies; Risk Assessment; United States; Young Adult | 2016 |
Pharmacokinetics of colistin methanesulfonate (CMS) in burn patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Area Under Curve; Burns; Colistin; Female; Humans; Male; Middle Aged | 2017 |
Stability study of sodium colistimethate-loaded lipid nanoparticles.
Topics: Colistin; Cystic Fibrosis; Drug Stability; Humans; Lipids; Nanoparticles; Pseudomonas aeruginosa; Pseudomonas Infections | 2016 |
Determination of Colistin and Colistimethate Levels in Human Plasma and Urine by High-Performance Liquid Chromatography-Tandem Mass Spectrometry.
Topics: Anti-Bacterial Agents; Calibration; Chromatography, High Pressure Liquid; Colistin; Drug Monitoring; Humans; Polymyxins; Tandem Mass Spectrometry | 2016 |
Substantial Targeting Advantage Achieved by Pulmonary Administration of Colistin Methanesulfonate in a Large-Animal Model.
Topics: Administration, Inhalation; Administration, Intravenous; Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Colistin; Cross-Over Studies; Drug Administration Schedule; Drug Dosage Calculations; Humans; Lung; Models, Statistical; Nebulizers and Vaporizers; Sheep | 2017 |
Reply to Zavascki and Nation.
Topics: Colistin | 2017 |
Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Biological Availability; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Kidney Diseases; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Treatment Outcome; Young Adult | 2017 |
Outcome analysis of colistin-treated burn center patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Burn Units; Burns; Colistin; Creatinine; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Outcome Assessment, Health Care; Pseudomonas aeruginosa; Pseudomonas Infections; Renal Replacement Therapy; Retrospective Studies; Treatment Failure | 2017 |
Potential Toxicity of Polymyxins in Human Lung Epithelial Cells.
Topics: Anti-Bacterial Agents; Apoptosis; Cell Line; Colistin; Humans; Membrane Potential, Mitochondrial; Microbial Sensitivity Tests; Mitochondria; Polymyxin B; Polymyxins | 2017 |
A simple method for assaying colistimethate sodium in pharmaceutical aerosol samples using high performance liquid chromatography.
Topics: Aerosols; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Colistin | 2017 |
Pharmacokinetics of nebulized colistin methanesulfonate in critically ill patients.
Topics: Administration, Inhalation; Adult; Aerosols; Aged; Aged, 80 and over; Anti-Bacterial Agents; Colistin; Critical Illness; Drug Administration Schedule; Female; Gram-Negative Bacterial Infections; Hospitalization; Humans; Lung; Male; Middle Aged; Nebulizers and Vaporizers; Pneumonia, Ventilator-Associated | 2017 |
Efficacy of a Fixed Combination of Tetracycline, Chloramphenicol, and Colistimethate Sodium for Treatment of Candida albicans Keratitis.
Topics: Animals; Anti-Bacterial Agents; Candida albicans; Candidiasis; Chloramphenicol; Colistin; Colony Count, Microbial; Corneal Ulcer; Drug Combinations; Drug Resistance, Fungal; Drug Synergism; Eye Infections, Fungal; Microbial Sensitivity Tests; Ophthalmic Solutions; Rabbits; Tetracycline; Treatment Outcome | 2017 |
Influence of diluent volume of colistimethate sodium on aerosol characteristics and pharmacokinetics in ventilator-associated pneumonia caused by MDR bacteria.
Topics: Administration, Inhalation; Adult; Aerosols; Aged; Anti-Bacterial Agents; Colistin; Cross-Over Studies; Drug Resistance, Multiple, Bacterial; Female; Humans; Lung; Male; Middle Aged; Nebulizers and Vaporizers; Pneumonia, Ventilator-Associated; Prospective Studies; Young Adult | 2018 |
A Population WB-PBPK Model of Colistin and its Prodrug CMS in Pigs: Focus on the Renal Distribution and Excretion.
Topics: Administration, Intravenous; Animals; Anti-Bacterial Agents; Colistin; Female; Kidney; Models, Animal; Models, Biological; Renal Elimination; Sus scrofa; Tissue Distribution | 2018 |
Incidence and risk factors of nephrotoxicity in patients on colistimethate sodium.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Colistin; Female; Humans; Incidence; Male; Middle Aged; Oman; Retrospective Studies; Risk Factors; Young Adult | 2018 |
Evaluation of nephrotoxicity and prognosis in patients treated with colistin due to hospital-acquired pneumonia.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Cohort Studies; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Pneumonia; Prognosis; Renal Insufficiency | 2017 |
A Whole-Body Physiologically Based Pharmacokinetic Model for Colistin and Colistin Methanesulfonate in Rat.
Topics: Activation, Metabolic; Animals; Anti-Bacterial Agents; Colistin; Computer Simulation; Injections, Intravenous; Male; Models, Biological; Prodrugs; Rats, Sprague-Dawley; Tissue Distribution | 2018 |
Pharmacokinetics of colistin in a 8-year-old child with acute bone infection.
Topics: Acute Disease; Anti-Bacterial Agents; Child; Colistin; Drug Administration Schedule; Humans; Male; Metabolic Clearance Rate; Osteomyelitis; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections | 2018 |
Metabolomics of colistin methanesulfonate treated Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Biomarkers; Colistin; Energy Metabolism; Gas Chromatography-Mass Spectrometry; Metabolomics; Mycobacterium tuberculosis | 2018 |
N-acetylcysteine suppresses colistimethate sodium-induced nephrotoxicity via activation of SOD2, eNOS, and MMP3 protein expressions.
Topics: Acetylcysteine; Acetylglucosaminidase; Acute Kidney Injury; Animals; Colistin; Creatinine; Disease Models, Animal; Free Radical Scavengers; Humans; Kidney; Male; Matrix Metalloproteinase 3; Nitric Oxide Synthase Type III; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxide Dismutase | 2018 |
Treatment outcomes of patients with non-bacteremic pneumonia caused by extensively drug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolates: Is there any benefit of adding tigecycline to aerosolized colistimethate sodium?
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Minocycline; Pneumonia; Retrospective Studies; Survival Rate; Taiwan; Tigecycline; Treatment Outcome | 2018 |
A case of pan-resistant Burkholderia cepacia complex bacteremic pneumonia, after lung transplantation treated with a targeted combination therapy.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Burkholderia cepacia complex; Burkholderia Infections; Colistin; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Humans; Lung Transplantation; Male; Pneumonia, Bacterial; Treatment Outcome; X-Rays | 2019 |
Oral Azithromycin Use and the Recovery of Lung Function from Pulmonary Exacerbations Treated with Intravenous Tobramycin or Colistimethate in Adults with Cystic Fibrosis.
Topics: Administration, Inhalation; Administration, Intravenous; Adult; Anti-Bacterial Agents; Azithromycin; Colistin; Cystic Fibrosis; Disease Progression; Female; Forced Expiratory Volume; Humans; Logistic Models; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tobramycin; Young Adult | 2019 |
Safety and effectiveness of sodium colistimethate-loaded nanostructured lipid carriers (SCM-NLC) against P. aeruginosa: in vitro and in vivo studies following pulmonary and intramuscular administration.
Topics: Animals; Colistin; Drug Carriers; Female; Inflammation; Injections, Intramuscular; Lipids; Lung; Mice, Inbred BALB C; Microbial Sensitivity Tests; Nanostructures; Pseudomonas aeruginosa; Tissue Distribution; Toxicity Tests; Treatment Outcome | 2019 |
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction.
Topics: Administration, Inhalation; Aerosols; Colistin; Cystic Fibrosis; Drug Compounding; Dry Powder Inhalers; Humans; Infections; Lung; Particle Size; Powders; Solvents | 2019 |
Systemic pharmacokinetics and safety of high doses of nebulized colistimethate sodium in critically ill patients with hospital-acquired and ventilator-associated pneumonia.
Topics: Administration, Inhalation; Aged; Aged, 80 and over; Anti-Bacterial Agents; Colistin; Critical Illness; Female; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Prospective Studies | 2019 |
Clinical and subclinical acute kidney injury in multidrug-resistant septic patients treated with colistimethate sodium: Incidence and clinical outcomes.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asymptomatic Diseases; Biomarkers; Colistin; Creatinine; Drug Resistance, Multiple, Bacterial; Fatty Acid-Binding Proteins; Female; Humans; Incidence; Lipocalin-2; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Risk Assessment; Risk Factors; Sepsis; Time Factors; Treatment Outcome | 2020 |
In vitro and in vivo assessment of the antibacterial activity of colistin alone and in combination with other antibiotics against Acinetobacter baumannii and Escherichia coli.
Topics: Acinetobacter baumannii; Administration, Intravenous; Animals; Anti-Bacterial Agents; Biofilms; Colistin; Disease Models, Animal; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; Monte Carlo Method; Sulbactam; Treatment Outcome; Urinary Tract Infections | 2020 |
Efficacy of colistimethate sodium as local application in necrotising fasciitis.
Topics: Administration, Topical; Adult; Colistin; Fasciitis, Necrotizing; Humans; Male; Treatment Outcome | 2019 |
The clinical profile and outcomes of adult patients given intravenous colistin for multidrug-resistant gram negative infections in a Philippine tertiary hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Hospitalization; Humans; Male; Meropenem; Middle Aged; Organ Dysfunction Scores; Philippines; Respiratory Tract Infections; Retrospective Studies; Tertiary Care Centers; Treatment Outcome; Young Adult | 2020 |
Colistin-induced acquired Bartter-like syndrome: an unusual cause of meltdown.
Topics: Alkalosis; Bartter Syndrome; Colistin; Diagnosis, Differential; Humans; Hypocalcemia; Hypokalemia; Male; Middle Aged; Polyuria | 2020 |
Quantitative determination of colistin A/B and colistin methanesulfonate in biological samples using hydrophilic interaction chromatography tandem mass spectrometry.
Topics: Animals; Anti-Bacterial Agents; Chromatography, Liquid; Colistin; Humans; Hydrophobic and Hydrophilic Interactions; Limit of Detection; Male; Rats; Rats, Wistar; Reproducibility of Results; Solid Phase Extraction; Tandem Mass Spectrometry | 2020 |
In vitro and in vivo antimicrobial activity of sodium colistimethate and amikacin-loaded nanostructured lipid carriers (NLC).
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Colistin; Drug Carriers; Drug Resistance, Bacterial; Humans; Lipids; Nanostructures; Pseudomonas aeruginosa | 2020 |
Clinical efficacy and pharmacokinetics of colistimethate sodium and colistin in critically ill patients in an Indian hospital with high endemic rates of multidrug-resistant Gram-negative bacterial infections: A prospective observational study.
Topics: Administration, Intravenous; Adult; Aged; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals; Humans; India; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2020 |
Long-term safety study of colistimethate sodium (Colobreathe®): Findings from the UK Cystic Fibrosis Registry.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Colistin; Cystic Fibrosis; Female; Humans; Male; Middle Aged; Pseudomonas Infections; Registries; Respiratory Tract Infections; Symptom Flare Up; United Kingdom | 2021 |
Assessment of colistimethate sodium (COLOBREATHE) risk minimization measures implemented in the European Union: A cross-sectional study.
Topics: Colistin; Cross-Sectional Studies; Drug-Related Side Effects and Adverse Reactions; Europe; Health Personnel; Humans; Inservice Training; Respiratory Therapy; Surveys and Questionnaires | 2020 |
Design of experiments guided multivariate calibration for the quantitation of injectable colistimethate sodium by ultra performance liquid chromatography - High resolution mass spectrometry.
Topics: Calibration; Chromatography, High Pressure Liquid; Chromatography, Liquid; Colistin; Gas Chromatography-Mass Spectrometry; Mass Spectrometry | 2020 |
Generation of a novel human dermal substitute functionalized with antibiotic-loaded nanostructured lipid carriers (NLCs) with antimicrobial properties for tissue engineering.
Topics: Amikacin; Anti-Bacterial Agents; Biocompatible Materials; Cell Proliferation; Cell Survival; Cells, Cultured; Colistin; Drug Carriers; Fibroblasts; Humans; Lipids; Nanostructures; Skin, Artificial; Tissue Engineering | 2020 |
Steady-state pharmacokinetic and pharmacodynamic profiling of colistin in critically ill patients with multi-drug-resistant gram-negative bacterial infections, along with differences in clinical, microbiological and safety outcome.
Topics: Administration, Inhalation; Administration, Intravenous; Adult; Anti-Bacterial Agents; Colistin; Critical Illness; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Patient Safety; Predictive Value of Tests; Prospective Studies; Risk Assessment; Treatment Outcome; Young Adult | 2021 |
ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development Study.
Topics: Adult; Anti-Bacterial Agents; Colistin; Critical Illness; Humans; Mobile Applications | 2020 |
Colistimethate Acidic Hydrolysis Revisited: Arrhenius Equation Modeling Using UPLC-QToF MS.
Topics: Chromatography, High Pressure Liquid; Colistin; Female; Humans; Hydrolysis; Male; Mass Spectrometry; Middle Aged; Models, Biological; Prodrugs | 2021 |
The first spectrofluorimetric approach for quantification of colistin sulfate and its prodrug colistimethate sodium in pharmaceutical dosage form and human plasma.
Topics: Colistin; Formaldehyde; Humans; Prodrugs; Spectrometry, Fluorescence | 2021 |
Tobramycin and Colistin display anti-inflammatory properties in CuFi-1 cystic fibrosis cell line.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cell Survival; Colistin; Cystic Fibrosis; Drug Combinations; Humans; Ibuprofen; Inflammation; Interleukin-8; Lipopolysaccharides; Pseudomonas aeruginosa; Tobramycin | 2021 |
Efficacy of Problem-Solving Intervention to Improve Adherence in Adolescents and Adults with Cystic Fibrosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Body Mass Index; Colistin; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Male; Medication Adherence; Patient-Centered Care; Problem Solving; Quality of Life; Tobramycin; Young Adult | 2021 |
Acute kidney injury in cystic fibrosis patients treated with intravenous colistimethate sodium or tobramycin.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tobramycin; Vancomycin | 2022 |
Colistimethate sodium-chitosan hydrogel for treating Gram-negative bacterial wound infections.
Topics: Anti-Bacterial Agents; Chitosan; Colistin; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Hydrogels; Microbial Sensitivity Tests; Wound Infection | 2022 |
Incidence of nephrotoxicity associated with intravenous colistimethate sodium administration for the treatment of multidrug-resistant gram-negative bacterial infections.
Topics: Colistin; Creatinine; Gram-Negative Bacterial Infections; Humans; Incidence; Pseudomonas aeruginosa; Renal Insufficiency; Retrospective Studies | 2022 |